GTHP
Guided Therapeutics, Inc.
Price Chart
Latest Quote
$0.26
-0.01 (-1.89%)
Current Price
| Previous Close | $0.27 |
| Open | $0.22 |
| Day High | $0.26 |
| Day Low | $0.22 |
| Volume | 7,100 |
Stock Information
| Shares Outstanding | 96.54M |
| Total Debt | $2.79M |
| Cash Equivalents | $369K |
| Revenue | $767K |
| Net Income | $-3.90M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $25.10M |
| EPS (TTM) | $-0.04 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $28.23M |
| Sales | $767K |
| Income | $-3.90M |
| Book/sh | $-0.06 |
| Cash/sh | $0.00 |
| Employees | 3 |
Financial Ratios
| Quick Ratio | 0.06 |
| Current Ratio | 0.15 |
Returns & Margins
| ROA | -109.88% |
| Gross Margin | 74.45% |
| Operating Margin | -294.65% |
Ownership
| Insider Ownership | 36.52% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 32.72 |
| P/B | -4.26 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.23 |
| SMA50 | $0.21 |
| SMA200 | $0.28 |
| RSI | 59.64 |
| ATR | 0.0236 |
| Shares Float | 40.10M |
| Volatility | 0.73 |
| Rel Volume | 2.22 |
Performance History
| Week | +34.02% |
| Month | +30.00% |
| Quarter | +0.00% |
| 6 Months | -18.75% |
| YTD | -51.85% |
| Year | +13.04% |
| 3 Years | +62.50% |
| 5 Years | -60.78% |
| 10 Years | -26.35% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $0.26 | 14,600 |
| 2026-06-22 | $0.26 | 300 |
| 2026-06-18 | $0.29 | 18,300 |
| 2026-06-17 | $0.29 | 15,000 |
| 2026-06-16 | $0.25 | 34,700 |
| 2026-06-15 | $0.19 | 1,100 |
| 2026-06-12 | $0.20 | 0 |
| 2026-06-11 | $0.20 | 0 |
| 2026-06-10 | $0.20 | 2,900 |
| 2026-06-09 | $0.20 | 0 |
| 2026-06-08 | $0.20 | 0 |
| 2026-06-05 | $0.20 | 11,300 |
| 2026-06-04 | $0.23 | 0 |
| 2026-06-03 | $0.23 | 1,500 |
| 2026-06-02 | $0.23 | 5,000 |
| 2026-06-01 | $0.20 | 600 |
| 2026-05-29 | $0.23 | 2,600 |
| 2026-05-28 | $0.23 | 5,600 |
| 2026-05-27 | $0.23 | 2,700 |
| 2026-05-26 | $0.19 | 15,100 |
About Guided Therapeutics, Inc.
Guided Therapeutics, Inc., a medical technology company, researches, develops, tests, manufactures, sells, and distributes medical devices in the United States and internationally. It offers LuViva, an advanced cervical scan non-invasive cervical cancer detection device that provides less invasive and painless alternative to conventional tests for identifying, screening, and detecting cervical cancers and precancers. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.
đ° Latest News
No news articles available at the moment. Check back later for updates on GTHP.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $5,000 | $62,000 | $81,000 | $61,000 |
| Cost Of Revenue | $5,000 | $62,000 | $81,000 | $61,000 |
| Total Revenue | $7,000 | $98,000 | $13,000 | $81,000 |
| Operating Revenue | $7,000 | $98,000 | $13,000 | $81,000 |
| Expenses | ||||
| Interest Expense | $381,000 | $278,000 | $582,000 | $1,150,000 |
| Total Expenses | $2,115,000 | $3,555,000 | $3,346,000 | $2,443,000 |
| Other Income Expense | $69,000 | $240,000 | $-426,000 | $1,442,000 |
| Other Non Operating Income Expenses | $18,000 | $39,000 | $16,000 | $507,000 |
| Net Non Operating Interest Income Expense | $-378,000 | $-272,000 | $-582,000 | $-1,150,000 |
| Interest Expense Non Operating | $381,000 | $278,000 | $582,000 | $1,150,000 |
| Operating Expense | $2,110,000 | $3,493,000 | $3,265,000 | $2,382,000 |
| Selling And Marketing Expense | $287,000 | $268,000 | $181,000 | $141,000 |
| General And Administrative Expense | $1,297,000 | $2,997,000 | $3,007,000 | $2,172,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-2,417,000 | $-3,489,000 | $-4,341,000 | $-2,070,000 |
| Net Interest Income | $-378,000 | $-272,000 | $-582,000 | $-1,150,000 |
| Interest Income | $3,000 | $6,000 | $0 | - |
| Normalized Income | $-2,468,000 | $-3,690,000 | $-3,899,000 | $-3,005,000 |
| Net Income From Continuing And Discontinued Operation | $-2,417,000 | $-3,489,000 | $-4,341,000 | $-2,070,000 |
| Total Operating Income As Reported | $-2,108,000 | $-3,457,000 | $-3,333,000 | $-2,362,000 |
| Net Income Common Stockholders | $-2,591,000 | $-3,759,000 | $-4,972,000 | $-2,431,000 |
| Net Income | $-2,417,000 | $-3,489,000 | $-4,341,000 | $-2,070,000 |
| Net Income Including Noncontrolling Interests | $-2,417,000 | $-3,489,000 | $-4,341,000 | $-2,070,000 |
| Net Income Continuous Operations | $-2,417,000 | $-3,489,000 | $-4,341,000 | $-2,070,000 |
| Pretax Income | $-2,417,000 | $-3,489,000 | $-4,341,000 | $-2,070,000 |
| Special Income Charges | $69,000 | $196,000 | $-469,000 | $578,000 |
| Interest Income Non Operating | $3,000 | $6,000 | $0 | - |
| Operating Income | $-2,108,000 | $-3,457,000 | $-3,333,000 | $-2,362,000 |
| Gross Profit | $2,000 | $36,000 | $-68,000 | $20,000 |
| Per Share | ||||
| Diluted EPS | $-0.05 | $-0.07 | $-0.15 | $-0.18 |
| Basic EPS | $-0.05 | $-0.07 | $-0.15 | $-0.18 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-1,992,000 | $-3,327,000 | $-3,245,000 | $-1,772,000 |
| Total Unusual Items | $51,000 | $201,000 | $-442,000 | $935,000 |
| Total Unusual Items Excluding Goodwill | $51,000 | $201,000 | $-442,000 | $935,000 |
| Reconciled Depreciation | $95,000 | $85,000 | $72,000 | $83,000 |
| EBITDA (Bullshit earnings) | $-1,941,000 | $-3,126,000 | $-3,687,000 | $-837,000 |
| EBIT | $-2,036,000 | $-3,211,000 | $-3,759,000 | $-920,000 |
| Diluted Average Shares | $57,339,000 | $51,131,000 | $32,505,000 | $13,377,000 |
| Basic Average Shares | $57,339,000 | $51,131,000 | $32,505,000 | $13,377,000 |
| Diluted NI Availto Com Stockholders | $-2,591,000 | $-3,759,000 | $-4,972,000 | $-2,431,000 |
| Otherunder Preferred Stock Dividend | $0 | $99,000 | $0 | - |
| Preferred Stock Dividends | $174,000 | $171,000 | $631,000 | $361,000 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Other Special Charges | $-69,000 | $-196,000 | $469,000 | $-578,000 |
| Gain On Sale Of Security | $-18,000 | $5,000 | $27,000 | $357,000 |
| Research And Development | $526,000 | $228,000 | $77,000 | $69,000 |
| Selling General And Administration | $1,584,000 | $3,265,000 | $3,188,000 | $2,313,000 |
| Other Gand A | $1,297,000 | $2,997,000 | $3,007,000 | $2,172,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-4,889,000 | $-3,806,000 | $-2,883,000 | $-5,445,000 |
| Total Assets | $1,378,000 | $1,669,000 | $3,366,000 | $2,040,000 |
| Total Non Current Assets | $181,000 | $276,000 | $362,000 | $403,000 |
| Other Non Current Assets | $17,000 | $17,000 | $17,000 | $17,000 |
| Current Assets | $1,197,000 | $1,393,000 | $3,004,000 | $1,637,000 |
| Other Current Assets | $173,000 | $163,000 | $137,000 | $377,000 |
| Inventory | $633,000 | $632,000 | $548,000 | $571,000 |
| Receivables | $3,000 | $7,000 | $6,000 | $46,000 |
| Accounts Receivable | $3,000 | $7,000 | $6,000 | $46,000 |
| Allowance For Doubtful Accounts Receivable | $-500 | $-2,000 | $-48,000 | $-126,000 |
| Gross Accounts Receivable | $3,500 | $9,000 | $54,000 | $172,000 |
| Cash Cash Equivalents And Short Term Investments | $388,000 | $591,000 | $2,313,000 | $643,000 |
| Cash And Cash Equivalents | $388,000 | $591,000 | $2,313,000 | $643,000 |
| Debt | ||||
| Net Debt | $1,616,000 | $1,123,000 | - | $1,864,000 |
| Total Debt | $2,159,000 | $1,960,000 | $2,263,000 | $2,899,000 |
| Long Term Debt And Capital Lease Obligation | $112,000 | $666,000 | $1,375,000 | $1,759,000 |
| Long Term Debt | $63,000 | $511,000 | $1,129,000 | $1,434,000 |
| Current Debt And Capital Lease Obligation | $2,047,000 | $1,294,000 | $888,000 | $1,140,000 |
| Current Debt | $1,941,000 | $1,203,000 | $809,000 | $1,073,000 |
| Other Current Borrowings | $1,779,000 | $1,144,000 | $751,000 | $985,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $6,267,000 | $5,475,000 | $6,249,000 | $7,485,000 |
| Total Non Current Liabilities Net Minority Interest | $112,000 | $666,000 | $1,380,000 | $1,791,000 |
| Current Liabilities | $6,155,000 | $4,809,000 | $4,869,000 | $5,694,000 |
| Other Current Liabilities | $118,000 | - | - | - |
| Current Deferred Liabilities | $849,000 | $424,000 | $509,000 | $337,000 |
| Current Notes Payable | $162,000 | $59,000 | $58,000 | $88,000 |
| Payables And Accrued Expenses | $2,691,000 | $2,663,000 | $2,987,000 | $3,557,000 |
| Interest Payable | $243,000 | $188,000 | $189,000 | $261,000 |
| Payables | $2,357,000 | $2,251,000 | $2,492,000 | $3,149,000 |
| Dividends Payable | $227,000 | $228,000 | $231,000 | $349,000 |
| Accounts Payable | $2,130,000 | $2,023,000 | $2,225,000 | $2,449,000 |
| Derivative Product Liabilities | - | $0 | $5,000 | $32,000 |
| Other Payable | - | - | $36,000 | $351,000 |
| Equity | ||||
| Common Stock Equity | $-7,888,000 | $-6,826,000 | $-5,964,000 | $-12,315,000 |
| Preferred Stock Equity | $2,999,000 | $3,020,000 | $3,081,000 | $6,870,000 |
| Total Equity Gross Minority Interest | $-4,889,000 | $-3,806,000 | $-2,883,000 | $-5,445,000 |
| Stockholders Equity | $-4,889,000 | $-3,806,000 | $-2,883,000 | $-5,445,000 |
| Retained Earnings | $-153,709,000 | $-151,118,000 | $-147,359,000 | $-142,387,000 |
| Other | ||||
| Ordinary Shares Number | $65,131,000 | $54,105,000 | $48,596,000 | $13,673,000 |
| Share Issued | $65,131,000 | $54,105,000 | $48,596,000 | $13,673,000 |
| Tangible Book Value | $-7,888,000 | $-6,826,000 | $-5,964,000 | $-12,315,000 |
| Invested Capital | $-5,884,000 | $-5,112,000 | $-4,026,000 | $-9,808,000 |
| Working Capital | $-4,958,000 | $-3,416,000 | $-1,865,000 | $-4,057,000 |
| Capital Lease Obligations | $155,000 | $246,000 | $325,000 | $392,000 |
| Total Capitalization | $-4,826,000 | $-3,295,000 | $-1,754,000 | $-4,011,000 |
| Treasury Stock | $132,000 | $132,000 | $132,000 | $132,000 |
| Additional Paid In Capital | $142,501,000 | $140,983,000 | $138,090,000 | $126,801,000 |
| Capital Stock | $6,451,000 | $6,461,000 | $6,518,000 | $10,273,000 |
| Common Stock | $3,452,000 | $3,441,000 | $3,437,000 | $3,403,000 |
| Preferred Stock | $2,999,000 | $3,020,000 | $3,081,000 | $6,870,000 |
| Long Term Capital Lease Obligation | $49,000 | $155,000 | $246,000 | $325,000 |
| Current Deferred Revenue | $849,000 | $424,000 | $509,000 | $337,000 |
| Current Capital Lease Obligation | $106,000 | $91,000 | $79,000 | $67,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $450,000 | $428,000 | $485,000 | $660,000 |
| Current Accrued Expenses | $334,000 | $412,000 | $495,000 | $408,000 |
| Net PPE | $164,000 | $259,000 | $345,000 | $386,000 |
| Accumulated Depreciation | $-1,591,000 | $-1,582,000 | $-1,750,000 | $-1,747,000 |
| Gross PPE | $1,755,000 | $1,841,000 | $2,095,000 | $2,133,000 |
| Leases | $12,000 | $12,000 | $12,000 | $12,000 |
| Other Properties | $1,092,000 | $1,178,000 | $1,386,000 | $1,420,000 |
| Machinery Furniture Equipment | $651,000 | $651,000 | $697,000 | $693,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-818,000 | $-818,000 | $-818,000 | $-785,000 |
| Finished Goods | $43,000 | $44,000 | $38,000 | $32,000 |
| Work In Process | $46,000 | $46,000 | $68,000 | $69,000 |
| Raw Materials | $1,362,000 | $1,360,000 | $1,260,000 | $1,255,000 |
| Dueto Related Parties Current | - | - | $39,000 | $87,000 |
| Construction In Progress | - | - | $0 | $8,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-1,119,000 | $-1,746,000 | $-1,510,000 | $-1,606,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-1,119,000 | $-1,746,000 | $-1,479,000 | $-1,592,000 |
| Cash Flow From Continuing Operating Activities | $-1,119,000 | $-1,746,000 | $-1,479,000 | $-1,592,000 |
| Operating Gains Losses | $-51,000 | $-201,000 | $442,000 | $-355,000 |
| Investing Activities | ||||
| Investing Cash Flow | - | $0 | $-31,000 | $-14,000 |
| Cash Flow From Continuing Investing Activities | - | $0 | $-31,000 | $-14,000 |
| Capital Expenditure | - | - | $-31,000 | $-14,000 |
| Financing Activities | ||||
| Financing Cash Flow | $916,000 | $24,000 | $3,180,000 | $2,067,000 |
| Cash Flow From Continuing Financing Activities | $916,000 | $24,000 | $3,180,000 | $2,067,000 |
| Net Other Financing Charges | $-29,000 | - | - | $312,000 |
| Issuance Of Capital Stock | - | $0 | $1,392,000 | $2,100,000 |
| Net Common Stock Issuance | - | $0 | $1,392,000 | $0 |
| Common Stock Issuance | - | $0 | $1,392,000 | $0 |
| Repurchase Of Capital Stock | - | - | $0 | $-125,000 |
| Net Preferred Stock Issuance | - | - | $0 | $1,975,000 |
| Preferred Stock Issuance | - | - | $0 | $2,100,000 |
| Other | ||||
| Repayment Of Debt | $-477,000 | $-412,000 | $-540,000 | $-1,468,000 |
| Issuance Of Debt | $587,000 | $0 | $0 | $1,248,000 |
| Interest Paid Supplemental Data | $51,000 | $107,000 | $149,000 | $557,000 |
| End Cash Position | $388,000 | $591,000 | $2,314,000 | $643,000 |
| Beginning Cash Position | $591,000 | $2,313,000 | $643,000 | $182,000 |
| Changes In Cash | $-203,000 | $-1,722,000 | $1,671,000 | $461,000 |
| Proceeds From Stock Option Exercised | $835,000 | $436,000 | $2,328,000 | $0 |
| Net Issuance Payments Of Debt | $110,000 | $-412,000 | $-540,000 | $-220,000 |
| Net Long Term Debt Issuance | $110,000 | $-412,000 | $-540,000 | $-220,000 |
| Long Term Debt Payments | $-477,000 | $-412,000 | $-540,000 | $-1,468,000 |
| Long Term Debt Issuance | $587,000 | $0 | $0 | $1,248,000 |
| Change In Working Capital | $1,003,000 | $-105,000 | $548,000 | $78,000 |
| Change In Other Working Capital | $425,000 | $-85,000 | $172,000 | $296,000 |
| Change In Other Current Liabilities | $-92,000 | $-79,000 | $-67,000 | $-56,000 |
| Change In Other Current Assets | $120,000 | $103,000 | $363,000 | $-309,000 |
| Change In Payables And Accrued Expense | $545,000 | $43,000 | $122,000 | $136,000 |
| Change In Inventory | $-1,000 | $-84,000 | $-58,000 | $33,000 |
| Change In Receivables | $6,000 | $-3,000 | $16,000 | $-22,000 |
| Changes In Account Receivables | $6,000 | $-3,000 | $16,000 | $-22,000 |
| Other Non Cash Items | $131,000 | $156,000 | $315,000 | $445,000 |
| Stock Based Compensation | $120,000 | $1,806,000 | $1,381,000 | $228,000 |
| Asset Impairment Charge | $0 | $2,000 | $23,000 | $0 |
| Depreciation Amortization Depletion | $95,000 | $85,000 | $72,000 | $83,000 |
| Depreciation And Amortization | $95,000 | $85,000 | $72,000 | $83,000 |
| Depreciation | $95,000 | $85,000 | $72,000 | $83,000 |
| Gain Loss On Investment Securities | $18,000 | $-5,000 | $-27,000 | $223,000 |
| Net Income From Continuing Operations | $-2,417,000 | $-3,489,000 | $-4,341,000 | $-2,071,000 |
| Net Short Term Debt Issuance | - | $-412,000 | $-540,000 | - |
| Short Term Debt Payments | - | $-412,000 | $-540,000 | - |
| Net PPE Purchase And Sale | - | $0 | $-31,000 | $-14,000 |
| Purchase Of PPE | - | $0 | $-31,000 | $-14,000 |
| Provisionand Write Offof Assets | - | $0 | $81,000 | $0 |
| Preferred Stock Payments | - | - | $0 | $-125,000 |
Fetched: 2026-02-02